Advertisement
Screener

Achieve Life Sciences, Inc. (ACHV) Preferred Stock, Shares Authorized

1.0 / 5 stars · 8/40 Roast Me

Achieve Life Sciences, Inc. Preferred Stock, Shares Authorized

Achieve Life Sciences, Inc. (ACHV) had Preferred Stock, Shares Authorized of 5.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-11

  • 2026-06-30: Preferred Stock, Shares Authorized 5.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 5.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 5.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-305.00M shares
10-Q · filed 2026-08-11
2026-03-315.00M shares
10-Q · filed 2026-05-12
2025-12-315.00M shares
10-K · filed 2026-03-24
2025-09-305.00M shares
10-Q · filed 2025-11-06
2025-06-305.00M shares
10-Q · filed 2025-08-07
2025-03-315.00M shares
10-Q · filed 2025-05-13
2024-12-315.00M shares
10-K · filed 2025-03-11
2024-09-305.00M shares
10-Q · filed 2024-11-07
2024-06-305.00M shares
10-Q · filed 2024-08-13
2024-03-315.00M shares
10-Q · filed 2024-05-09
2023-12-315.00M shares
10-K · filed 2024-03-28
2023-09-305.00M shares
10-Q · filed 2023-11-09
2023-06-305.00M shares
10-Q · filed 2023-08-14
2023-03-315.00M shares
10-Q · filed 2023-05-09
2022-12-315.00M shares
10-K · filed 2023-03-16
2022-09-305.00M shares
10-Q · filed 2022-11-14
2022-06-305.00M shares
10-Q · filed 2022-08-11
2022-03-315.00M shares
10-Q · filed 2022-05-12
2021-12-315.00M shares
10-K · filed 2022-03-10
2021-09-305.00M shares
10-Q · filed 2021-11-09
2021-06-305.00M shares
10-Q · filed 2021-08-12
2021-03-315.00M shares
10-Q · filed 2021-05-13
2020-12-315.00M shares
10-K · filed 2021-03-11
2020-09-305.00M shares
10-Q · filed 2020-11-12
2020-06-305.00M shares
10-Q · filed 2020-08-06
2020-03-315.00M shares
10-Q · filed 2020-05-14
2019-12-315.00M shares
10-K · filed 2020-03-13
2019-09-305.00M shares
10-Q · filed 2019-11-06
2019-06-305.00M shares
10-Q · filed 2019-08-08
2019-03-315.00M shares
10-Q · filed 2019-05-15
2018-12-315.00M shares
10-Q · filed 2019-11-06
2018-09-305.00M shares
10-Q · filed 2018-11-07
2018-06-305.00M shares
10-Q · filed 2018-08-08
2018-03-315.00M shares
10-Q · filed 2018-05-09
2017-12-315.00M shares
10-K · filed 2019-03-14
2017-09-305.00M shares
10-Q · filed 2017-11-09
2017-06-305.00M shares
10-Q · filed 2017-07-31
2017-03-315.00M shares
10-Q · filed 2017-05-15
2016-12-315.00M shares
10-K · filed 2017-02-23
2016-09-305.00M shares
10-Q · filed 2016-11-10
2016-06-305.00M shares
10-Q · filed 2016-08-04
2016-03-315.00M shares
10-Q · filed 2016-05-12
2015-12-315.00M shares
10-K · filed 2016-03-09
2015-09-305.00M shares
10-Q · filed 2015-11-12
2015-06-305.00M shares
10-Q · filed 2015-08-13
2015-03-315.00M shares
10-Q · filed 2015-05-14
2014-12-315.00M shares
10-K · filed 2015-03-26
2014-09-305.00M shares
10-Q · filed 2014-10-30
2014-06-305.00M shares
10-Q · filed 2014-08-07
2014-03-315.00M shares
10-Q · filed 2014-04-30
2013-12-315.00M shares
10-K · filed 2014-03-11
2013-09-305.00M shares
10-Q · filed 2013-11-07
2013-06-305.00M shares
10-Q · filed 2013-08-08
2013-03-315.00M shares
10-Q · filed 2013-05-02
2012-12-315.00M shares
10-K · filed 2013-03-07
2012-09-305.00M shares
10-Q · filed 2012-11-08
2012-06-305.00M shares
10-Q · filed 2012-08-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92